![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Kopran Research Laboratories Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Atenolol, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 1998-017 - Rev 07
This Chemical Type CEP, issued on June 20, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 703 associated with this CEP further emphasizes